Edwards Lifesciences Corp (NYSE:EW)
| CAPS Rating |
|
|---|---|
| Open | $72.88 |
| Previous Close | $73.31 |
| Daily Range | $72.54 - $74.02 |
| 52-Week Range | $61.59 - $91.82 |
| Market Cap | $8.49B |
| P/E Ratio | 37.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,044,943 |
| Average Daily Volume | 0 |
How do you think EW will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
EW Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
EW News and Commentary
- Edwards Lifesciences Shares Got Crushed: What You Need to Know – The Motley Fool
- Edwards Lifesciences Hurt by Competition – The Motley Fool
- EW Misses on Revs, 1Q Guidance Weak - Analyst Blog – NASDAQ
- Edwards Lifesciences Misses on Revenue but Beats on EPS – The Motley Fool
- The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medic – NASDAQ
- Positive Outcome on MDT's CoreValve - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medic – NASDAQ
- Why the Street Should Love Edwards Lifesciences' Earnings – The Motley Fool
- Milestone for Stereotaxis' Niobe ES - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Edwards Lifesciences, Medtronic, Boston Scientific, St Jude Medic – NASDAQ
- Heart-to-Heart: Evolving TAVR Market - Analyst Blog – NASDAQ
- Why Edwards Lifesciences May Be About to Take Off – The Motley Fool
- 3 Stocks Shaking the Market – The Motley Fool
- Stereotaxis Begins Epoch Shipment - Analyst Blog – NASDAQ
- This Just In: More Upgrades and Downgrades – The Motley Fool
- Edwards '12 Looks Good with Sapien - Analyst Blog – NASDAQ
- Is St. Jude Medical's Growth for Real? – The Motley Fool
- 1 Reason Medtronic's Earnings Aren't So Hot – The Motley Fool
- 5 Stocks I'm Buying Now – Blog at The Motley Fool
- Earnings Preview: Medtronic - Analyst Blog – NASDAQ

RSS Headlines
Fool UK